Abstract
A large submucous uterine leiomyoma and pregnancy: clinical case
Highlights
Leiomyoma or uterine myoma is a monoclonal tumor that develops from a single mutant smooth muscle cell of the vascular wall without the ability of growth control [1,2,3,4]
Ultrasound research at 11 weeks determined subserous uterine leiomyoma, but the patient was registered for pregnancy only at 20 weeks
There has been an increase in patients of reproductive age with uterine myoma, planning pregnancy
Summary
Leiomyoma or uterine myoma (hysteromyoma) is a monoclonal tumor that develops from a single mutant smooth muscle cell of the vascular wall without the ability of growth control [1,2,3,4] It can be detected in 77% of women in the population, and there is a tendency to «rejuvenation» of the disease over the past 10 years: in Russia, its prevalence in women under the age of 30 years increased from 2% to 12.5%, in the USA, in women of 18-30 years – to 43-57% [2,4]. The choice of treatment method depends on the woman's age, tumor size, symptoms severity, the number and location of nodes, the risk of malignancy, reproductive goals, on the desire to preserve the uterus [1,2,3,4]. There is always a risk of recurrence after organsaving operations, which reaches 15-45% [2]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
